Cascade Prodrug Receives Gap Funds From ONAMI

EUGENE, Ore. – (November 7, 2014) – Cascade Prodrug, Inc. agreed to terms for funding from Oregon Nanoscience and Microtechnologies Institue, (ONAMI) in the budgeted amount of $250,000 for a development project to be conducted by Dr. Adam Alani, Assistant Professor, Oregon State University College of Pharmacy. The collaboration is focused on the development of a nanoparticle formulation for enhancing the pharmacokinetics of Hypoxia-Activated Prodrugs for treating ovarian cancer. “Dr. Alani brings deep experience in formulating drugs to our program and provides an exciting new dimension to Cascade’s prodrug technology platform,” stated August Sick, Cofounder and Managing Director.

About CascadeProdrug

No Comments

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Powered by WishList Member - Membership Software